Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/10/2023 → 30/09/2027 |
Funding
- Quell Therapeutics Ltd: £70,000.00
Optimization of the potency and specificity of engineered regulatory t cells to treat inflammatory and fibrotic liver diseases
- Safinia, Niloufar (Primary Investigator)
- Sanchez Fueyo, Alberto (Co-Investigator)
Project: Research